268 related articles for article (PubMed ID: 20807147)
1. Effects of firocoxib, meloxicam, and tepoxalin administration on eicosanoid production in target tissues of healthy cats.
Goodman LA; Torres BT; Reynolds LR; Budsberg SC
Am J Vet Res; 2010 Sep; 71(9):1067-73. PubMed ID: 20807147
[TBL] [Abstract][Full Text] [Related]
2. Effects of firocoxib, meloxicam, and tepoxalin on prostanoid and leukotriene production by duodenal mucosa and other tissues of osteoarthritic dogs.
Punke JP; Speas AL; Reynolds LR; Budsberg SC
Am J Vet Res; 2008 Sep; 69(9):1203-9. PubMed ID: 18764695
[TBL] [Abstract][Full Text] [Related]
3. Effects of firocoxib and tepoxalin on healing in a canine gastric mucosal injury model.
Goodman L; Torres B; Punke J; Reynolds L; Speas A; Ellis A; Budsberg S
J Vet Intern Med; 2009; 23(1):56-62. PubMed ID: 19175721
[TBL] [Abstract][Full Text] [Related]
4. In vivo effects of tepoxalin, an inhibitor of cyclooxygenase and lipoxygenase, on prostanoid and leukotriene production in dogs with chronic osteoarthritis.
Agnello KA; Reynolds LR; Budsberg SC
Am J Vet Res; 2005 Jun; 66(6):966-72. PubMed ID: 16008217
[TBL] [Abstract][Full Text] [Related]
5. In vivo effects of meloxicam and aspirin on blood, gastric mucosal, and synovial fluid prostanoid synthesis in dogs.
Jones CJ; Streppa HK; Harmon BG; Budsberg SC
Am J Vet Res; 2002 Nov; 63(11):1527-31. PubMed ID: 12428662
[TBL] [Abstract][Full Text] [Related]
6. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
[TBL] [Abstract][Full Text] [Related]
7. Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings.
Engelhardt G; Bögel R; Schnitzler C; Utzmann R
Biochem Pharmacol; 1996 Jan; 51(1):29-38. PubMed ID: 8534265
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects.
Panara MR; Renda G; Sciulli MG; Santini G; Di Giamberardino M; Rotondo MT; Tacconelli S; Seta F; Patrono C; Patrignani P
J Pharmacol Exp Ther; 1999 Jul; 290(1):276-80. PubMed ID: 10381787
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of three formulations of firocoxib in healthy horses.
Holland B; Fogle C; Blikslager AT; Curling A; Barlow BM; Schirmer J; Davis JL
J Vet Pharmacol Ther; 2015 Jun; 38(3):249-56. PubMed ID: 25378135
[TBL] [Abstract][Full Text] [Related]
10. Biochemical activity, pharmacokinetics and tolerability of tepoxalin, a cyclooxygenase/5-lipoxygenase inhibitor, in man.
Depré M; Van Hecken A; Verbesselt R; Verpooten GA; Arnout J; Brunner F; Jurgens A; Pousset V; Chow A; Baldauf C; Vermylen J; De Broe M; De Schepper PJ
Int J Clin Pharmacol Res; 1996; 16(1):1-8. PubMed ID: 9001924
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase expression and prostanoid production in pyloric and duodenal mucosae in dogs after administration of nonsteroidal anti-inflammatory drugs.
Wooten JG; Blikslager AT; Ryan KA; Marks SL; Law JM; Lascelles BD
Am J Vet Res; 2008 Apr; 69(4):457-64. PubMed ID: 18380576
[TBL] [Abstract][Full Text] [Related]
12. Effect of nonsteroidal anti-inflammatory drugs with varied cyclooxygenase-2 selectivity on cyclooxygenase protein and prostanoid concentrations in pyloric and duodenal mucosa of dogs.
Wooten JG; Blikslager AT; Marks SL; Law JM; Graeber EC; Lascelles BD
Am J Vet Res; 2009 Oct; 70(10):1243-9. PubMed ID: 19795939
[TBL] [Abstract][Full Text] [Related]
13. Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5-lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation.
Kirchner T; Aparicio B; Argentieri DC; Lau CY; Ritchie DM
Prostaglandins Leukot Essent Fatty Acids; 1997 Jun; 56(6):417-23. PubMed ID: 9223651
[TBL] [Abstract][Full Text] [Related]
14. Effect of flunixin meglumine and firocoxib on ex vivo cyclooxygenase activity in horses undergoing elective surgery.
Duz M; Parkin TD; Cullander RM; Marshall JF
Am J Vet Res; 2015 Mar; 76(3):208-15. PubMed ID: 25710756
[TBL] [Abstract][Full Text] [Related]
15. Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients.
Frommel TO; Dyavanapalli M; Oldham T; Kazi N; Lietz H; Liao Y; Mobarhan S
Clin Cancer Res; 1997 Feb; 3(2):209-13. PubMed ID: 9815674
[TBL] [Abstract][Full Text] [Related]
16. Meloxicam, 15 mg/day, spares platelet function in healthy volunteers.
de Meijer A; Vollaard H; de Metz M; Verbruggen B; Thomas C; Novakova I
Clin Pharmacol Ther; 1999 Oct; 66(4):425-30. PubMed ID: 10546927
[TBL] [Abstract][Full Text] [Related]
17. Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers.
Stichtenoth DO; Wagner B; Frölich JC
J Investig Med; 1997 Feb; 45(2):44-9. PubMed ID: 9084574
[TBL] [Abstract][Full Text] [Related]
18. Antiinflammatory effect of tepoxalin: blood and synovial tissue studied in patients with knee arthrosis.
Willburger RE; Wittenberg RH; Schmidt K; Kleemeyer KS; Peskar BA
Acta Orthop Scand; 1998 Jun; 69(3):295-300. PubMed ID: 9703407
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study.
Lipscomb GR; Wallis N; Armstrong G; Rees WD
Br J Clin Pharmacol; 1998 Aug; 46(2):133-7. PubMed ID: 9723821
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the clinical use of tepoxalin and meloxicam in cats.
Charlton AN; Benito J; Simpson W; Freire M; Lascelles BD
J Feline Med Surg; 2013 Aug; 15(8):678-90. PubMed ID: 23349526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
